The Connected Clinician's Top 5 Stories of the Week - July 28


Everything the clinician needs to stay connected.

Human Trials Begin on First-Ever Preventative Vaccine for T1 Diabetes

FDA Rejects Lilly’s Baricitinib

GOP Skinny Repeal Fails in 49-51 Vote

HCV Eradicated in Patients of Infected Kidney Transplants

HIV Risk Greater Among Women Due to Greater Risk Behaviors

There was plenty of big news in medicine this week, as the US Food and Drug Administration got busy with several new approvals (and rejections), and Republicans failed (again) to strip down Obamacare. Here are the most popular stories of the week.Finnish researchers have already proven the safety and efficacy of a preventative T1 diabetes vaccine in mice. Now, they’re attempting to prove its worth in humans. The potential is huge, according to lead researcher Heikki Hyöty.Lilly’s latest attempt at a commercialized prescription treatment for Rheumatoid Arthritis took a hit on Tuesday, as the FDA rejected its New Drug Application, citing safety and dosage questions.Yet another failed health care repeal tarnished Republicans’ reputation this week, as John McCain (R-AZ) and 2 other Republican senators voted against, and ultimately doomed what has emerged as Mitch McConnell’s last-ditch effort to repeal Obamacare.10 patients received kidney transplants from donors who were infected with HCV. All 10 were cured of the condition following the transplant, suggesting that a there is a huge pool of donors that are going unused as the kidney transplant waiting list grows each day.Per a new study from the IS Centers for Disease Control and Prevention (CDC), women are more likely to participate in sexual behaviors that carry greater risk for transmission of HIV, including intercourse with multiple partners concurrently and using condoms inconsistently.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
Stephen Congly, MD | Credit: University of Calgary
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
© 2024 MJH Life Sciences

All rights reserved.